Literature DB >> 30334111

TB or Not TB: Crohn's Disease, Peritoneal Tuberculosis, or Both?

Miquell Miller1, Kim-Nhien Vu2, Allison Zemek3, Andrew Shelton4, Cindy Kin4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30334111     DOI： 10.1007/s10620-018-5334-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  15 in total

1.  Safety of resuming tumour necrosis factor inhibitors in patients who developed tuberculosis as a complication of previous TNF inhibitors.

Authors:  You Jae Kim; Yong-Gil Kim; Tae Sun Shim; Bon San Koo; Seokchan Hong; Chang-Keun Lee; Bin Yoo
Journal:  Rheumatology (Oxford)       Date:  2014-03-27       Impact factor: 7.580

2.  Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.

Authors:  F Tubach; D Salmon; P Ravaud; Y Allanore; P Goupille; M Bréban; B Pallot-Prades; S Pouplin; A Sacchi; R M Chichemanian; S Bretagne; D Emilie; M Lemann; O Lortholary; O Lorthololary; X Mariette
Journal:  Arthritis Rheum       Date:  2009-07

Review 3.  Ustekinumab: A Review in Moderate to Severe Crohn's Disease.

Authors:  Yvette N Lamb; Sean T Duggan
Journal:  Drugs       Date:  2017-07       Impact factor: 9.546

Review 4.  Meta-Analytic Bayesian Model For Differentiating Intestinal Tuberculosis from Crohn's Disease.

Authors:  Julajak Limsrivilai; Andrew B Shreiner; Ananya Pongpaibul; Charlie Laohapand; Rewat Boonanuwat; Nonthalee Pausawasdi; Supot Pongprasobchai; Sathaporn Manatsathit; Peter D R Higgins
Journal:  Am J Gastroenterol       Date:  2017-01-03       Impact factor: 10.864

5.  Granulomas of intestinal tuberculosis and Crohn's disease can be differentiated by CD73 cell surface marker expression: a pilot study.

Authors:  Rupa Banerjee; M Balaji; M Sasikala; S Anuradha; G V Rao; D Nageshwar Reddy
Journal:  Dig Dis Sci       Date:  2013-04-27       Impact factor: 3.199

6.  Life-threatening disseminated tuberculosis as a complication of treatment by infliximab for Crohn's disease: report of two cases, including cerebral tuberculomas and miliary tuberculosis.

Authors:  Claire Tissot; Sébastien Couraud; Lun Meng; Philippe Girard; Virginie Avrillon; Laurence Gérinière; Emilie Perrot; Pierre-Jean Souquet
Journal:  J Crohns Colitis       Date:  2012-06-28       Impact factor: 9.071

Review 7.  Intestinal tuberculosis and Crohn's disease: challenging differential diagnosis.

Authors:  Jia Yi Ma; Jin Lu Tong; Zhi Hua Ran
Journal:  J Dig Dis       Date:  2016-03       Impact factor: 2.325

8.  Granulomatous infectious diseases associated with tumor necrosis factor antagonists.

Authors:  R S Wallis; M S Broder; J Y Wong; M E Hanson; D O Beenhouwer
Journal:  Clin Infect Dis       Date:  2004-04-15       Impact factor: 9.079

9.  Confluent granulomas and ulcers lined by epithelioid histiocytes: new ideal method for differentiation of ITB and CD? A meta analysis.

Authors:  Juan Du; Yan-Yan Ma; Ha Xiang; You-Ming Li
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

Review 10.  Next generation of biologics for the treatment of Crohn's disease: an evidence-based review on ustekinumab.

Authors:  Aranzazu Jauregui-Amezaga; Michael Somers; Heiko De Schepper; Elisabeth Macken
Journal:  Clin Exp Gastroenterol       Date:  2017-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.